0000950123-24-003797.txt : 20240503 0000950123-24-003797.hdr.sgml : 20240503 20240503163558 ACCESSION NUMBER: 0000950123-24-003797 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20240331 FILED AS OF DATE: 20240503 DATE AS OF CHANGE: 20240503 EFFECTIVENESS DATE: 20240503 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Versant Venture Management, LLC CENTRAL INDEX KEY: 0001560009 ORGANIZATION NAME: IRS NUMBER: 954767945 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-16849 FILM NUMBER: 24913814 BUSINESS ADDRESS: STREET 1: ONE SANSOME STREET, SUITE 1650 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 650-233-7877 MAIL ADDRESS: STREET 1: ONE SANSOME STREET, SUITE 1650 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 13F-HR 1 primary_doc.xml X0202 13F-HR LIVE 0001560009 XXXXXXXX 03-31-2024 03-31-2024 false Versant Venture Management, LLC

One Sansome Street, Suite 1650 San Francisco CA 94104

13F HOLDINGS REPORT 028-16849 000161130 802-75823 N Max Eisenberg (415) 801-8100 /s/ Max Eisenberg San Francisco CA 05-03-2024 0 7 103136206 false INFORMATION TABLE 2 32106.xml INFORMATION TABLE FOR FORM 13F Adverum Biotechnologies, Inc. Common Stock 00773U108 7166463 506822 SH OTR 0 506822 0 Aligos Therapeutics, Inc. Common Stock 01626L105 2273973 2320381 SH OTR 0 2320381 0 CRISPR Therapeutics AG Common Stock H17182108 33981713 498558 SH OTR 0 498558 0 Gritstone Oncology, Inc. Common Stock 39868T105 9152156 3561150 SH OTR 0 3561150 0 Passage Bio, Inc. Common Stock 702712100 6695688 4959769 SH OTR 0 4959769 0 Repare Therapeutics, Inc. Common Stock 760273102 12465754 2646657 SH OTR 0 2646657 0 Skye Bioscience, Inc. Common Stock 83086J200 31400459 2007702 SH OTR 0 2007702 0